Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
34.53 USD | -0.23% |
|
+1.32% | +46.94% |
06-25 | Select Medical Holdings, Concentra Group Holdings Report Launch of $750 Million Offering | MT |
05-06 | UBS Adjusts Select Medical Price Target to $34 From $31, Maintains Neutral Rating | MT |
Summary
- Overall, and from a short-term perspective, the company presents an interesting fundamental situation.
- According to Refinitiv, the company's ESG score for its industry is poor.
Strengths
- Analysts have a positive opinion on this stock. Average consensus recommends overweighting or purchasing the stock.
- Over the past four months, analysts' average price target has been revised upwards significantly.
- Considering the small differences between the analysts' various estimates, the group's business visibility is good.
- The divergence of price targets given by the various analysts who make up the consensus is relatively low, suggesting a consensus method of evaluating the company and its prospects.
Weaknesses
- The company is in debt and has limited leeway for investment
- The company appears highly valued given the size of its balance sheet.
- The company is not the most generous with respect to shareholders' compensation.
- For the past year, analysts have significantly revised downwards their profit estimates.
- The overall consensus opinion of analysts has deteriorated sharply over the past four months.
- Over the past twelve months, analysts' opinions have been revised negatively.
Ratings chart - Surperformance
Chart ESG Refinitiv
Sector: Healthcare Facilities & Services
1st Jan change | Capi. | Investor Rating | ESG Refinitiv | |
---|---|---|---|---|
+46.94% | 4.49B | C- | ||
+25.78% | 89.17B | C+ | ||
-23.45% | 75.87B | B- | ||
+2.54% | 27.41B | C+ | ||
-8.56% | 17.52B | B | ||
+0.71% | 17.04B | A- | ||
+0.30% | 15.36B | A- | ||
+78.55% | 13.18B | C+ | ||
+77.76% | 13.67B | C- | ||
-25.79% | 12.83B | - | - |
Financials
Valuation
Momentum
Consensus
Business Predictability
Environment
Governance
Controversy
Technical analysis
- Stock Market
- Equities
- SEM Stock
- Ratings Select Medical Holdings Corporation